Foreign Aid, Antipoverty Advocates, Others Must Back Deficit Commission Report Efforts To Restore Budget Choices “Over the past few weeks, I’ve had a chance to interview some amazing people,” ranging from Bill Gates to scientists and teachers, who are all concerned about impending budget cuts,Â the New York Times’ David Brooks…
India could soon become a site for clinical trials to evaluate the effectiveness of a dengue vaccine, the Times of India reports. According to the drug controller general of India (DCGI), vaccine maker Sanofi Pasteur recently submitted a proposal to test the vaccine to the country. If approved, India would be the latest country to join in studies of the vaccine’s effectiveness in adults and children, which are already taking place in Australia, Colombia, Honduras, Mexico, Peru, Philippines, Puerto Rico, Singapore, Thailand and Vietnam, according to the newspaper.
“Kenya on Monday became the first African country to introduce a routine vaccine against pneumococcal disease, which claims the lives of more than half a million children under five each year,” Deutsche Presse Agentur/The Hindu reports. The GAVI Alliance, which is supporting the vaccine’s roll out, “is aiming to introduce the vaccine to 19 developing countries – including Nicaragua, Guyana, Yemen and Sierra Leone – within a year and hopes to reach more than 40 nations by 2015, depending on funding.”
Also In Global Health News: Global Alcohol-Related Deaths; Pentavalent Vaccine Plant To Resume Operations; Harm-Reduction In Russia; IDUs In Tanzania; MDG Tracking Program In Kenya
Alcohol Kills 2.5M Annually, WHO Report Says “Alcohol abuse is killing 2.5 million people each year,” according to a report from the WHO, which said that about “4 percent of all deaths worldwide are attributable to alcohol,” the Associated Press/Washington Post reports.Â “The main causes of alcohol-related deaths are injuries incurred…
On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).
“A rise in global funding for research into neglected diseases needs to be matched by a continued focus on delivering practical new ways to curb sickness in the developing world,” according to the third annual report by the Global Funding of Innovation for Neglected Diseases (G-FINDER) released on Wednesday, Reuters reports.
Factors Contributing to HealthÂ Of Women Worldwide: The Kaiser Family Foundation features a narrated slide tutorial by epidemiologist Laurel Spielberg on the health issues facing women around the world. The tutorial touches on issues such as economic status and biological, social, and cultural factors that affect women’s health, as well as…
During a meeting in Puerto Rico on Thursday to discuss recent progress towards fighting dengue, researchers voiced optimism over advances in the development of vaccines to prevent the spread of the virus, “which kills 25,000 people every year,” Agence France-Presse reports.
TIME reports on an oral cholera vaccination program to kick off on Thursday in Bangladesh that researchers hope will determine how good of a “weapon” the mass vaccination strategy can be “against an old disease” (Marshall, 2/15).
Also In Global Health News: Methadone Maintenance In Africa; Dengue Vaccine; HIV/AIDS In Ukraine; Human Rights In Russia; Chevron, USAID $50M MOU
First Methadone Maintenance Program In Sub-Saharan Africa Opens Its Doors In Tanzania The New York Times examines “the first methadone maintenance program in sub-Saharan Africa,” which opened this month in a hospital in Dar es Salaam, Tanzania, with funding support from PEPFAR. “While heroin use is not common in Africa,…